SS Innovations International, Inc. announced on December 10, 2024, that its SSi Mantra surgical robotic system has received Central Drugs Standard Control Organization (CDSCO) regulatory approval for Telesurgery and Teleproctoring capabilities. This makes it the first and only surgical robotic system in India authorized for these advanced remote surgical procedures.
The CDSCO, India's equivalent to the U.S. FDA, granted this approval, positioning the SSi Mantra to decentralize and democratize access to robotic surgical expertise. This is particularly impactful for addressing healthcare gaps in remote areas where specialized medical care has historically been limited.
This achievement marks a significant step forward in India's healthcare landscape, reinforcing the country's position in healthcare innovation. The approval opens new possibilities for accessible, high-quality healthcare across India and beyond, transforming surgical practices and enhancing access to advanced treatments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.